0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global C13 Stable Isotope Labeled Biomolecules Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Published Date: October 2022
|
Report Code: QYRE-Auto-9U2298
Home | Market Reports | Science| Chemistry
Global C13 Stable Isotope Labeled Biomolecules Market Insights and Forecast to 2028
BUY CHAPTERS

Global C13 Stable Isotope Labeled Biomolecules Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Auto-9U2298
Report
October 2022
Pages:111
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for C13 Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for C13 Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for C13 Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of C13 Stable Isotope Labeled Biomolecules include Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife BV, WITEGA Laboratorien, Omicron Biochemicals and Icon Isotopes, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the C13 Stable Isotope Labeled Biomolecules manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional C13 Stable Isotope Labeled Biomolecules market. Further, it explains the major drivers and regional dynamics of the global C13 Stable Isotope Labeled Biomolecules market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Cambridge Isotope Laboratories
Sigma-Aldrich
Thermo Fisher Scientific
LGC Standards
Toronto Research Chemicals
IsoLife BV
WITEGA Laboratorien
Omicron Biochemicals
Icon Isotopes
Medical Isotopes
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

C13 Stable Isotope Labeled Biomolecules Segment by Type

Medical C13 Stable Isotope Labeled Biomolecules
Others

C13 Stable Isotope Labeled Biomolecules Segment by Application

Scientific Research
Medical
Industrial
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the C13 Stable Isotope Labeled Biomolecules market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for C13 Stable Isotope Labeled Biomolecules, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of C13 Stable Isotope Labeled Biomolecules, also provides the sales of main regions and countries. Highlights of the upcoming market potential for C13 Stable Isotope Labeled Biomolecules, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the C13 Stable Isotope Labeled Biomolecules sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global C13 Stable Isotope Labeled Biomolecules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for C13 Stable Isotope Labeled Biomolecules sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife BV, WITEGA Laboratorien, Omicron Biochemicals and Icon Isotopes, etc.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Medical C13 Stable Isotope Labeled Biomolecules
1.2.3 Others
1.3 Market Segment by Application
1.3.1 Global C13 Stable Isotope Labeled Biomolecules Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Industrial
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global C13 Stable Isotope Labeled Biomolecules Market Size (2017-2028)
2.1.1 Global C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028)
2.1.2 Global C13 Stable Isotope Labeled Biomolecules Sales (2017-2028)
2.2 Global C13 Stable Isotope Labeled Biomolecules Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Regions (2017-2022)
2.2.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Regions (2017-2022)
2.3 Global C13 Stable Isotope Labeled Biomolecules Market Size Forecast by Region
2.3.1 Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Region (2023-2028)
2.3.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Region (2023-2028)
2.4 Global Top C13 Stable Isotope Labeled Biomolecules Regions (Countries) Ranking by Market Size
2.5 C13 Stable Isotope Labeled Biomolecules Market Dynamics
2.5.1 C13 Stable Isotope Labeled Biomolecules Market Trends
2.5.2 C13 Stable Isotope Labeled Biomolecules Market Drivers
2.5.3 C13 Stable Isotope Labeled Biomolecules Market Challenges
2.5.4 C13 Stable Isotope Labeled Biomolecules Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top C13 Stable Isotope Labeled Biomolecules Manufacturers by Sales (2017-2022)
3.1.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Manufacturers (2017-2022)
3.1.2 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by C13 Stable Isotope Labeled Biomolecules Sales in 2021
3.2 Global Top Manufacturers C13 Stable Isotope Labeled Biomolecules by Revenue
3.2.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturers (2017-2022)
3.2.2 Top C13 Stable Isotope Labeled Biomolecules Manufacturers Covered: Ranking by Revenue
3.2.3 Global C13 Stable Isotope Labeled Biomolecules Revenue Share by Manufacturers (2017-2022)
3.2.4 Global C13 Stable Isotope Labeled Biomolecules Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in C13 Stable Isotope Labeled Biomolecules as of 2021)
3.4 Global C13 Stable Isotope Labeled Biomolecules Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers C13 Stable Isotope Labeled Biomolecules Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into C13 Stable Isotope Labeled Biomolecules Market
3.7 Key Manufacturers C13 Stable Isotope Labeled Biomolecules Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global C13 Stable Isotope Labeled Biomolecules Market Size by Type
4.1 Global C13 Stable Isotope Labeled Biomolecules Historic Market Review by Type (2017-2022)
4.1.1 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2017-2022)
4.1.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2017-2022)
4.1.3 C13 Stable Isotope Labeled Biomolecules Price by Type (2017-2022)
4.2 Global C13 Stable Isotope Labeled Biomolecules Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Type (2023-2028)
4.2.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Type (2023-2028)
4.2.3 C13 Stable Isotope Labeled Biomolecules Price Forecast by Type (2023-2028)
5 Global C13 Stable Isotope Labeled Biomolecules Market Size by Application
5.1 Global C13 Stable Isotope Labeled Biomolecules Historic Market Review by Application (2017-2022)
5.1.1 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2017-2022)
5.1.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2017-2022)
5.1.3 C13 Stable Isotope Labeled Biomolecules Price by Application (2017-2022)
5.2 Global C13 Stable Isotope Labeled Biomolecules Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Application (2023-2028)
5.2.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Application (2023-2028)
5.2.3 C13 Stable Isotope Labeled Biomolecules Price Forecast by Application (2023-2028)
6 North America
6.1 North America C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Company
6.1.1 North America C13 Stable Isotope Labeled Biomolecules Sales by Company (2017-2022)
6.1.2 North America C13 Stable Isotope Labeled Biomolecules Revenue by Company (2017-2022)
6.2 North America C13 Stable Isotope Labeled Biomolecules Market Size by Type
6.2.1 North America C13 Stable Isotope Labeled Biomolecules Sales by Type (2017-2028)
6.2.2 North America C13 Stable Isotope Labeled Biomolecules Revenue by Type (2017-2028)
6.3 North America C13 Stable Isotope Labeled Biomolecules Market Size by Application
6.3.1 North America C13 Stable Isotope Labeled Biomolecules Sales by Application (2017-2028)
6.3.2 North America C13 Stable Isotope Labeled Biomolecules Revenue by Application (2017-2028)
6.4 North America C13 Stable Isotope Labeled Biomolecules Market Size by Country
6.4.1 North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2017-2028)
6.4.2 North America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Company
7.1.1 Europe C13 Stable Isotope Labeled Biomolecules Sales by Company (2017-2022)
7.1.2 Europe C13 Stable Isotope Labeled Biomolecules Revenue by Company (2017-2022)
7.2 Europe C13 Stable Isotope Labeled Biomolecules Market Size by Type
7.2.1 Europe C13 Stable Isotope Labeled Biomolecules Sales by Type (2017-2028)
7.2.2 Europe C13 Stable Isotope Labeled Biomolecules Revenue by Type (2017-2028)
7.3 Europe C13 Stable Isotope Labeled Biomolecules Market Size by Application
7.3.1 Europe C13 Stable Isotope Labeled Biomolecules Sales by Application (2017-2028)
7.3.2 Europe C13 Stable Isotope Labeled Biomolecules Revenue by Application (2017-2028)
7.4 Europe C13 Stable Isotope Labeled Biomolecules Market Size by Country
7.4.1 Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2017-2028)
7.4.2 Europe C13 Stable Isotope Labeled Biomolecules Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Company
8.1.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Company (2017-2022)
8.1.2 Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Company (2017-2022)
8.2 Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Size by Type
8.2.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Type (2017-2028)
8.2.2 Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Type (2017-2028)
8.3 Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Size by Application
8.3.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Application (2017-2028)
8.3.2 Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Application (2017-2028)
8.4 Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Size by Region
8.4.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Region
8.4.2 Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Company
9.1.1 Latin America C13 Stable Isotope Labeled Biomolecules Sales by Company (2017-2022)
9.1.2 Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Company (2017-2022)
9.2 Latin America C13 Stable Isotope Labeled Biomolecules Market Size by Type
9.2.1 Latin America C13 Stable Isotope Labeled Biomolecules Sales by Type (2017-2028)
9.2.2 Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Type (2017-2028)
9.3 Latin America C13 Stable Isotope Labeled Biomolecules Market Size by Application
9.3.1 Latin America C13 Stable Isotope Labeled Biomolecules Sales by Application (2017-2028)
9.3.2 Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Application (2017-2028)
9.4 Latin America C13 Stable Isotope Labeled Biomolecules Market Size by Country
9.4.1 Latin America C13 Stable Isotope Labeled Biomolecules Sales by Country (2017-2028)
9.4.2 Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Company
10.1.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Company (2017-2022)
10.1.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Company (2017-2022)
10.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Size by Type
10.2.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Type (2017-2028)
10.2.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Type (2017-2028)
10.3 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Size by Application
10.3.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Application (2017-2028)
10.3.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Application (2017-2028)
10.4 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Size by Country
10.4.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country (2017-2028)
10.4.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Cambridge Isotope Laboratories
11.1.1 Cambridge Isotope Laboratories Corporation Information
11.1.2 Cambridge Isotope Laboratories Overview
11.1.3 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Products and Services
11.1.5 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules SWOT Analysis
11.1.6 Cambridge Isotope Laboratories Recent Developments
11.2 Sigma-Aldrich
11.2.1 Sigma-Aldrich Corporation Information
11.2.2 Sigma-Aldrich Overview
11.2.3 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Products and Services
11.2.5 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules SWOT Analysis
11.2.6 Sigma-Aldrich Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Corporation Information
11.3.2 Thermo Fisher Scientific Overview
11.3.3 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Products and Services
11.3.5 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules SWOT Analysis
11.3.6 Thermo Fisher Scientific Recent Developments
11.4 LGC Standards
11.4.1 LGC Standards Corporation Information
11.4.2 LGC Standards Overview
11.4.3 LGC Standards C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 LGC Standards C13 Stable Isotope Labeled Biomolecules Products and Services
11.4.5 LGC Standards C13 Stable Isotope Labeled Biomolecules SWOT Analysis
11.4.6 LGC Standards Recent Developments
11.5 Toronto Research Chemicals
11.5.1 Toronto Research Chemicals Corporation Information
11.5.2 Toronto Research Chemicals Overview
11.5.3 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Products and Services
11.5.5 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules SWOT Analysis
11.5.6 Toronto Research Chemicals Recent Developments
11.6 IsoLife BV
11.6.1 IsoLife BV Corporation Information
11.6.2 IsoLife BV Overview
11.6.3 IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 IsoLife BV C13 Stable Isotope Labeled Biomolecules Products and Services
11.6.5 IsoLife BV C13 Stable Isotope Labeled Biomolecules SWOT Analysis
11.6.6 IsoLife BV Recent Developments
11.7 WITEGA Laboratorien
11.7.1 WITEGA Laboratorien Corporation Information
11.7.2 WITEGA Laboratorien Overview
11.7.3 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Products and Services
11.7.5 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules SWOT Analysis
11.7.6 WITEGA Laboratorien Recent Developments
11.8 Omicron Biochemicals
11.8.1 Omicron Biochemicals Corporation Information
11.8.2 Omicron Biochemicals Overview
11.8.3 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Products and Services
11.8.5 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules SWOT Analysis
11.8.6 Omicron Biochemicals Recent Developments
11.9 Icon Isotopes
11.9.1 Icon Isotopes Corporation Information
11.9.2 Icon Isotopes Overview
11.9.3 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Products and Services
11.9.5 Icon Isotopes C13 Stable Isotope Labeled Biomolecules SWOT Analysis
11.9.6 Icon Isotopes Recent Developments
11.10 Medical Isotopes
11.10.1 Medical Isotopes Corporation Information
11.10.2 Medical Isotopes Overview
11.10.3 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Products and Services
11.10.5 Medical Isotopes C13 Stable Isotope Labeled Biomolecules SWOT Analysis
11.10.6 Medical Isotopes Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 C13 Stable Isotope Labeled Biomolecules Value Chain Analysis
12.2 C13 Stable Isotope Labeled Biomolecules Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 C13 Stable Isotope Labeled Biomolecules Production Mode & Process
12.4 C13 Stable Isotope Labeled Biomolecules Sales and Marketing
12.4.1 C13 Stable Isotope Labeled Biomolecules Sales Channels
12.4.2 C13 Stable Isotope Labeled Biomolecules Distributors
12.5 C13 Stable Isotope Labeled Biomolecules Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
    Table 1. Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Medical C13 Stable Isotope Labeled Biomolecules
    Table 3. Major Manufacturers of Others
    Table 4. Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global C13 Stable Isotope Labeled Biomolecules Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 6. Global C13 Stable Isotope Labeled Biomolecules Sales by Region (2017-2022) & (K MT)
    Table 7. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2017-2022)
    Table 8. Global C13 Stable Isotope Labeled Biomolecules Revenue by Region (2017-2022) & (US$ Million)
    Table 9. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2017-2022)
    Table 10. Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Region (2023-2028) & (K MT)
    Table 11. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share Forecast by Region (2023-2028)
    Table 12. Global C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 13. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share Forecast by Region (2023-2028)
    Table 14. Top C13 Stable Isotope Labeled Biomolecules Regions (Countries) Ranking by Market Size (US$ Million) in 2021
    Table 15. C13 Stable Isotope Labeled Biomolecules Market Trends
    Table 16. C13 Stable Isotope Labeled Biomolecules Market Drivers
    Table 17. C13 Stable Isotope Labeled Biomolecules Market Challenges
    Table 18. C13 Stable Isotope Labeled Biomolecules Market Restraints
    Table 19. Global C13 Stable Isotope Labeled Biomolecules Sales by Manufacturers (2017-2022) & (K MT)
    Table 20. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Manufacturers (2017-2022)
    Table 21. Global C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 22. Ranking of Global Top C13 Stable Isotope Labeled Biomolecules Manufacturers by Revenue (US$ Million) in 2021
    Table 23. C13 Stable Isotope Labeled Biomolecules Revenue Share by Manufacturers (2017-2022)
    Table 24. Global C13 Stable Isotope Labeled Biomolecules Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in C13 Stable Isotope Labeled Biomolecules as of 2021)
    Table 26. Key Manufacturers C13 Stable Isotope Labeled Biomolecules Average Selling Price (ASP) & (2017-2022) & (USD/MT)
    Table 27. Key Manufacturers C13 Stable Isotope Labeled Biomolecules Plants/Factories Distribution
    Table 28. Key Manufacturers C13 Stable Isotope Labeled Biomolecules Area Served
    Table 29. Date of Key Manufacturers Enter into C13 Stable Isotope Labeled Biomolecules Market
    Table 30. Key Manufacturers C13 Stable Isotope Labeled Biomolecules Product Type
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global C13 Stable Isotope Labeled Biomolecules Sales (K MT) by Type (2017-2022)
    Table 33. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Type (2017-2022)
    Table 34. Global C13 Stable Isotope Labeled Biomolecules Revenue (US$ Million) Market Share by Type (2017-2022)
    Table 35. Global C13 Stable Isotope Labeled Biomolecules Price (K MT) by Type (2017-2022)
    Table 36. Global C13 Stable Isotope Labeled Biomolecules Sales (K MT) by Type (2023-2028)
    Table 37. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Type (2023-2028)
    Table 38. Global C13 Stable Isotope Labeled Biomolecules Revenue (US$ Million) Market Share by Type (2023-2028)
    Table 39. Global C13 Stable Isotope Labeled Biomolecules Revenue Share by Type (2023-2028)
    Table 40. Global C13 Stable Isotope Labeled Biomolecules Price (K MT) by Type (2023-2028)
    Table 41. Global C13 Stable Isotope Labeled Biomolecules Sales (K MT) by Application (2017-2022)
    Table 42. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Application (2017-2022)
    Table 43. Global C13 Stable Isotope Labeled Biomolecules Revenue (US$ Million) Market Share by Application (2017-2022)
    Table 44. Global C13 Stable Isotope Labeled Biomolecules Price (K MT) by Application (2017-2022)
    Table 45. Global C13 Stable Isotope Labeled Biomolecules Sales (K MT) by Application (2023-2028)
    Table 46. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Application (2023-2028)
    Table 47. Global C13 Stable Isotope Labeled Biomolecules Revenue (US$ Million) Market Share by Application (2023-2028)
    Table 48. Global C13 Stable Isotope Labeled Biomolecules Revenue Share by Application (2023-2028)
    Table 49. Global C13 Stable Isotope Labeled Biomolecules Price (K MT) by Application (2023-2028)
    Table 50. North America C13 Stable Isotope Labeled Biomolecules Sales by Company (2017-2022) & (K MT)
    Table 51. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Company (2017-2022)
    Table 52. North America C13 Stable Isotope Labeled Biomolecules Revenue by Company (2017-2022) & (US$ Million)
    Table 53. North America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Company (2017-2022)
    Table 54. North America C13 Stable Isotope Labeled Biomolecules Sales by Type (2017-2022) & (K MT)
    Table 55. North America C13 Stable Isotope Labeled Biomolecules Sales by Type (2023-2028) & (K MT)
    Table 56. North America C13 Stable Isotope Labeled Biomolecules Revenue by Type (2017-2022) & (US$ Million)
    Table 57. North America C13 Stable Isotope Labeled Biomolecules Revenue by Type (2023-2028) & (US$ Million)
    Table 58. North America C13 Stable Isotope Labeled Biomolecules Sales by Application (2017-2022) & (K MT)
    Table 59. North America C13 Stable Isotope Labeled Biomolecules Sales by Application (2023-2028) & (K MT)
    Table 60. North America C13 Stable Isotope Labeled Biomolecules Revenue by Application (2017-2022) & (US$ Million)
    Table 61. North America C13 Stable Isotope Labeled Biomolecules Revenue by Application (2023-2028) & (US$ Million)
    Table 62. North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2017-2022) & (K MT)
    Table 63. North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2023-2028) & (K MT)
    Table 64. North America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2017-2022) & (US$ Million)
    Table 65. North America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2023-2028) & (US$ Million)
    Table 66. Europe C13 Stable Isotope Labeled Biomolecules Sales by Company (2017-2022) & (K MT)
    Table 67. Europe C13 Stable Isotope Labeled Biomolecules Sales Market Share by Company (2017-2022)
    Table 68. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Company (2017-2022) & (US$ Million)
    Table 69. Europe C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Company (2017-2022)
    Table 70. Europe C13 Stable Isotope Labeled Biomolecules Sales by Type (2017-2022) & (K MT)
    Table 71. Europe C13 Stable Isotope Labeled Biomolecules Sales by Type (2023-2028) & (K MT)
    Table 72. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Europe C13 Stable Isotope Labeled Biomolecules Sales by Application (2017-2022) & (K MT)
    Table 75. Europe C13 Stable Isotope Labeled Biomolecules Sales by Application (2023-2028) & (K MT)
    Table 76. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2017-2022) & (K MT)
    Table 79. Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2023-2028) & (K MT)
    Table 80. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Country (2017-2022) & (US$ Million)
    Table 81. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Country (2023-2028) & (US$ Million)
    Table 82. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Company (2017-2022) & (K MT)
    Table 83. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Market Share by Company (2017-2022)
    Table 84. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Company (2017-2022) & (US$ Million)
    Table 85. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Company (2017-2022)
    Table 86. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Type (2017-2022) & (K MT)
    Table 87. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Type (2023-2028) & (K MT)
    Table 88. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Type (2017-2022) & (US$ Million)
    Table 89. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Type (2023-2028) & (US$ Million)
    Table 90. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Application (2017-2022) & (K MT)
    Table 91. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Application (2023-2028) & (K MT)
    Table 92. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Application (2017-2022) & (US$ Million)
    Table 93. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Application (2023-2028) & (US$ Million)
    Table 94. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Region (2017-2022) & (K MT)
    Table 95. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Region (2023-2028) & (K MT)
    Table 96. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Region (2017-2022) & (US$ Million)
    Table 97. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Region (2023-2028) & (US$ Million)
    Table 98. Latin America C13 Stable Isotope Labeled Biomolecules Sales by Company (2017-2022) & (K MT)
    Table 99. Latin America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Company (2017-2022)
    Table 100. Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Company (2017-2022) & (US$ Million)
    Table 101. Latin America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Company (2017-2022)
    Table 102. Latin America C13 Stable Isotope Labeled Biomolecules Sales by Type (2017-2022) & (K MT)
    Table 103. Latin America C13 Stable Isotope Labeled Biomolecules Sales by Type (2023-2028) & (K MT)
    Table 104. Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Type (2017-2022) & (US$ Million)
    Table 105. Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Type (2023-2028) & (US$ Million)
    Table 106. Latin America C13 Stable Isotope Labeled Biomolecules Sales by Application (2017-2022) & (K MT)
    Table 107. Latin America C13 Stable Isotope Labeled Biomolecules Sales by Application (2023-2028) & (K MT)
    Table 108. Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Application (2017-2022) & (US$ Million)
    Table 109. Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Application (2023-2028) & (US$ Million)
    Table 110. Latin America C13 Stable Isotope Labeled Biomolecules Sales by Country (2017-2022) & (K MT)
    Table 111. Latin America C13 Stable Isotope Labeled Biomolecules Sales by Country (2023-2028) & (K MT)
    Table 112. Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2017-2022) & (US$ Million)
    Table 113. Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2023-2028) & (US$ Million)
    Table 114. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Company (2017-2022) & (K MT)
    Table 115. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Market Share by Company (2017-2022)
    Table 116. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Company (2017-2022) & (US$ Million)
    Table 117. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Company (2017-2022)
    Table 118. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Type (2017-2022) & (K MT)
    Table 119. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Type (2023-2028) & (K MT)
    Table 120. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Type (2017-2022) & (US$ Million)
    Table 121. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Type (2023-2028) & (US$ Million)
    Table 122. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Application (2017-2022) & (K MT)
    Table 123. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Application (2023-2028) & (K MT)
    Table 124. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Application (2017-2022) & (US$ Million)
    Table 125. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Application (2023-2028) & (US$ Million)
    Table 126. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country (2017-2022) & (K MT)
    Table 127. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country (2023-2028) & (K MT)
    Table 128. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Country (2017-2022) & (US$ Million)
    Table 129. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Country (2023-2028) & (US$ Million)
    Table 130. Cambridge Isotope Laboratories Corporation Information
    Table 131. Cambridge Isotope Laboratories Description and Overview
    Table 132. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
    Table 133. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Product and Services
    Table 134. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules SWOT Analysis
    Table 135. Cambridge Isotope Laboratories Recent Developments
    Table 136. Sigma-Aldrich Corporation Information
    Table 137. Sigma-Aldrich Description and Overview
    Table 138. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
    Table 139. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Product and Services
    Table 140. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules SWOT Analysis
    Table 141. Sigma-Aldrich Recent Developments
    Table 142. Thermo Fisher Scientific Corporation Information
    Table 143. Thermo Fisher Scientific Description and Overview
    Table 144. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
    Table 145. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Product and Services
    Table 146. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules SWOT Analysis
    Table 147. Thermo Fisher Scientific Recent Developments
    Table 148. LGC Standards Corporation Information
    Table 149. LGC Standards Description and Overview
    Table 150. LGC Standards C13 Stable Isotope Labeled Biomolecules Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
    Table 151. LGC Standards C13 Stable Isotope Labeled Biomolecules Product and Services
    Table 152. LGC Standards C13 Stable Isotope Labeled Biomolecules SWOT Analysis
    Table 153. LGC Standards Recent Developments
    Table 154. Toronto Research Chemicals Corporation Information
    Table 155. Toronto Research Chemicals Description and Overview
    Table 156. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
    Table 157. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Product and Services
    Table 158. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules SWOT Analysis
    Table 159. Toronto Research Chemicals Recent Developments
    Table 160. IsoLife BV Corporation Information
    Table 161. IsoLife BV Description and Overview
    Table 162. IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
    Table 163. IsoLife BV C13 Stable Isotope Labeled Biomolecules Product and Services
    Table 164. IsoLife BV C13 Stable Isotope Labeled Biomolecules SWOT Analysis
    Table 165. IsoLife BV Recent Developments
    Table 166. WITEGA Laboratorien Corporation Information
    Table 167. WITEGA Laboratorien Description and Overview
    Table 168. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
    Table 169. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Product and Services
    Table 170. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules SWOT Analysis
    Table 171. WITEGA Laboratorien Recent Developments
    Table 172. Omicron Biochemicals Corporation Information
    Table 173. Omicron Biochemicals Description and Overview
    Table 174. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
    Table 175. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Product and Services
    Table 176. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules SWOT Analysis
    Table 177. Omicron Biochemicals Recent Developments
    Table 178. Icon Isotopes Corporation Information
    Table 179. Icon Isotopes Description and Overview
    Table 180. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
    Table 181. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Product and Services
    Table 182. Icon Isotopes C13 Stable Isotope Labeled Biomolecules SWOT Analysis
    Table 183. Icon Isotopes Recent Developments
    Table 184. Medical Isotopes Corporation Information
    Table 185. Medical Isotopes Description and Overview
    Table 186. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
    Table 187. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Product and Services
    Table 188. Medical Isotopes C13 Stable Isotope Labeled Biomolecules SWOT Analysis
    Table 189. Medical Isotopes Recent Developments
    Table 190. Key Raw Materials Lists
    Table 191. Raw Materials Key Suppliers Lists
    Table 192. C13 Stable Isotope Labeled Biomolecules Distributors List
    Table 193. C13 Stable Isotope Labeled Biomolecules Customers List
    Table 194. Research Programs/Design for This Report
    Table 195. Key Data Information from Secondary Sources
    Table 196. Key Data Information from Primary Sources
List of Figures
    Figure 1. C13 Stable Isotope Labeled Biomolecules Product Picture
    Figure 2. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type in 2021 & 2028
    Figure 3. Medical C13 Stable Isotope Labeled Biomolecules Product Picture
    Figure 4. Others Product Picture
    Figure 5. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application in 2021 & 2028
    Figure 6. Scientific Research Use Case
    Figure 7. Medical Use Case
    Figure 8. Industrial Use Case
    Figure 9. Others Use Case
    Figure 10. C13 Stable Isotope Labeled Biomolecules Report Years Considered
    Figure 11. Global C13 Stable Isotope Labeled Biomolecules Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global C13 Stable Isotope Labeled Biomolecules Market Size 2017-2028 (US$ Million)
    Figure 13. Global C13 Stable Isotope Labeled Biomolecules Sales (2017-2022) & (K MT)
    Figure 14. Global C13 Stable Isotope Labeled Biomolecules Market Size Market Share by Region: 2021 VS 2028
    Figure 15. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2017-2022)
    Figure 16. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region in 2021
    Figure 17. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region in 2017 VS 2021
    Figure 18. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Manufacturers in 2021
    Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by C13 Stable Isotope Labeled Biomolecules Sales in 2021
    Figure 20. C13 Stable Isotope Labeled Biomolecules Revenue Share by Manufacturers in 2021
    Figure 21. C13 Stable Isotope Labeled Biomolecules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 22. Global C13 Stable Isotope Labeled Biomolecules Revenue Share by Type (2017-2022)
    Figure 23. Global C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate by Type in 2017 & 2021
    Figure 24. Global C13 Stable Isotope Labeled Biomolecules Revenue Share by Application (2017-2022)
    Figure 25. Global C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate by Application in 2017 & 2021
    Figure 26. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2017-2028)
    Figure 27. North America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2017-2028)
    Figure 28. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2017-2028)
    Figure 29. North America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2017-2028)
    Figure 30. North America C13 Stable Isotope Labeled Biomolecules Sales Share by Country (2017-2028)
    Figure 31. North America C13 Stable Isotope Labeled Biomolecules Revenue Share by Country (2017-2028)
    Figure 32. U.S. C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 33. Canada C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 34. Europe C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2017-2028)
    Figure 35. Europe C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2017-2028)
    Figure 36. Europe C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2017-2028)
    Figure 37. Europe C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2017-2028)
    Figure 38. Europe C13 Stable Isotope Labeled Biomolecules Sales Share by Country (2017-2028)
    Figure 39. Europe C13 Stable Isotope Labeled Biomolecules Revenue Share by Country (2017-2028)
    Figure 40. Germany C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 41. France C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 42. U.K. C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 43. Italy C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 44. Russia C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 45. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2017-2028)
    Figure 46. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2017-2028)
    Figure 47. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2017-2028)
    Figure 48. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2017-2028)
    Figure 49. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Share by Region (2017-2028)
    Figure 50. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue Share by Region (2017-2028)
    Figure 51. China C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 52. Japan C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 53. South Korea C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 54. India C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 55. Australia C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 56. China Taiwan C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 57. Indonesia C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 58. Thailand C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 59. Malaysia C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 60. Latin America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2017-2028)
    Figure 61. Latin America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2017-2028)
    Figure 62. Latin America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2017-2028)
    Figure 63. Latin America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2017-2028)
    Figure 64. Latin America C13 Stable Isotope Labeled Biomolecules Sales Share by Country (2017-2028)
    Figure 65. Latin America C13 Stable Isotope Labeled Biomolecules Revenue Share by Country (2017-2028)
    Figure 66. Mexico C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 67. Brazil C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 68. Argentina C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 69. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2017-2028)
    Figure 70. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2017-2028)
    Figure 71. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2017-2028)
    Figure 72. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2017-2028)
    Figure 73. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Share by Country (2017-2028)
    Figure 74. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Share by Country (2017-2028)
    Figure 75. Turkey C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 77. UAE C13 Stable Isotope Labeled Biomolecules Revenue (2017-2028) & (US$ Million)
    Figure 78. C13 Stable Isotope Labeled Biomolecules Value Chain
    Figure 79. C13 Stable Isotope Labeled Biomolecules Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5600

This license allows only one user to access the PDF.
Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global High Volume Magnetic Stirrer Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-5L10555
Tue Jan 31 00:00:00 UTC 2023

Add to Cart

Global XRF Sulfur Analyzer Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-16R10701
Tue Jan 31 00:00:00 UTC 2023

Add to Cart

Global Benchtop Nuclear Magnetic Resonance (NMR) Spectrometer Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-2256
Thu Jan 26 00:00:00 UTC 2023

Add to Cart

Global Cyclooctene (COE) Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-18Y9573
Mon Jan 23 00:00:00 UTC 2023

Add to Cart